SYROS PHARMACEUTICALS, INC. Unbilled Receivables, Current
SYROS PHARMACEUTICALS, INC. had Unbilled Receivables, Current of $1.67 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2024-03-27
- 2023-09-30: Unbilled Receivables, Current $1.67M.
- 2023-06-30: Unbilled Receivables, Current $1.76M.
- 2023-03-31: Unbilled Receivables, Current $1.76M.
- 2022-12-31: Unbilled Receivables, Current $1.69M.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2023-09-30 | $1.67M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.76M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.76M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.69M 10-K · filed 2024-03-27 |